M&A Deal Summary

Abbott Laboratories Acquires Solvay Pharmaceuticals

On February 15, 2010, Abbott Laboratories acquired life science company Solvay Pharmaceuticals from Solvay for 6.1B USD

Acquisition Highlights
  • This is Abbott Laboratories’ 7th transaction in the Life Science sector.
  • This is Abbott Laboratories’ 3rd largest (disclosed) transaction.
  • This is Abbott Laboratories’ 1st transaction in Belgium.

M&A Deal Summary
Date 2010-02-15
Target Solvay Pharmaceuticals
Sector Life Science
Buyer(s) Abbott Laboratories
Sellers(s) Solvay
Deal Type Add-on Acquisition
Deal Value 6.1B USD

Target

Solvay Pharmaceuticals

Brussels, Belgium
Solvay Pharmaceuticals is a provider of generic drugs and other pharmaceutical products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 40.1B USD (2023)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 19 of 35
Sector (Life Science) 7 of 11
Type (Add-on Acquisition) 19 of 35
Country (Belgium) 1 of 1
Year (2010) 1 of 4
Size (of disclosed) 3 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-18 STARLIMS Technologies

Tel Aviv, Israel

STARLIMS Technologies is a provider of laboratory information management systems. STARLIMS Technologies is based in Tel Aviv, Israel.

Buy $123M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-09 Facet Biotech

Redwood City, California, United States

Facet Biotech is a biotechnology company dedicated to advancing its pipeline of five clinical-stage products focused in multiple sclerosis and oncology, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics.

Buy $450M

Seller(S) 1

SELLER

Solvay

Brussels, Belgium
Category Company
Founded 1863
Sector Chemicals
Employees9,000
Revenue 6.0B EUR (2023)
DESCRIPTION

Solvay is a chemical company that harnesses the power of chemistry to create innovative, sustainable solutions that answer the world’s most essential needs such as purifying the air we breathe and the water we drink, preserving our food supplies, protecting our health and well-being, creating eco-friendly clothing, making the tires of our cars more sustainable and cleaning and protecting our homes. Solvay was founded in 1863 and is based in Brussels, Belgium.

DEAL STATS #
Overall 1 of 10
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 2
Country (Belgium) 1 of 3
Year (2010) 1 of 1
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-06-14 Unimed Pharmaceuticals

Buffalo Grove, Illinois, United States

Unimed Pharmaceuticals LLC is a manufacturer of drugs.

Buy $123M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-08-24 The Rhodia Group

Courbevoie, France

The Rhodia Group is a manufacturer of specialty chemicals.

Buy €3.4B
Mergr

Product

Company

Legal